Motley Fool  Nov 11  Comment 
Arena Pharmaceuticals stock has fallen hard after a slower than expected launch of its fat-fighting pill Belviq. During its third-quarter conference call, though, management gave three reasons investors should be optimistic moving forward.
JCN Network  Nov 4  Comment 
Eisai Co., Ltd. announced today that in a Phase II clinical study investigating the serotonin 2C receptor agonist lorcaserin hydrochloride as a potential aid for smoking cessation conducted by Arena Pharmaceuticals, Inc. and its U.S. subsidiary...
Motley Fool  Nov 4  Comment 
A prescription growth rate of 30% sounds good, but Belviq has such low sales, it's hard to get too excited yet. If phase 3 trials pan out, long-term growth will likely come from use as a smoking cessation drug and as a combination product for...
FiercePharma  Nov 3  Comment 
With a marketing push from partner Eisai behind it, Arena Pharmaceuticals more than doubled the revenue it earned from weight-loss drug Belviq in the last quarter but reported a Q3 loss of $10.7 million, or $0.05 per share.
Benzinga  Nov 3  Comment 
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) provided a corporate update and reported financial results Monday for the third quarter ended September 30, 2014. The company reported revenues of $8.2 million, below estimates of $10.87 million and...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki